1. Jin, Tao, Tan, Xuling, Shi, Xiaoliu, Wang, Chunyu, Yang, Mei. 2020. Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson's Disease. In Neuromolecular medicine, 23, 285-291. doi:10.1007/s12017-020-08617-z. https://pubmed.ncbi.nlm.nih.gov/33001354/
2. Poleshko, Andrey, Katz, Richard A. 2014. Specifying peripheral heterochromatin during nuclear lamina reassembly. In Nucleus (Austin, Tex.), 5, 32-9. doi:10.4161/nucl.28167. https://pubmed.ncbi.nlm.nih.gov/24637393/
3. Ren, Xiaolei, Long, Meijun, Li, Zhihong, Qi, Lin, Yang, Mei. 2020. Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathway. In Cell death & disease, 11, 464. doi:10.1038/s41419-020-2640-8. https://pubmed.ncbi.nlm.nih.gov/32541902/
4. Yang, M, Lewinska, M, Fan, X, Zhu, J, Yuan, Z-M. 2016. PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis. In Oncogene, 35, 5527-5538. doi:10.1038/onc.2016.93. https://pubmed.ncbi.nlm.nih.gov/27041574/
5. Li, Fangfang, Zhang, Chundong, Fu, Lijuan. 2019. PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway. In PloS one, 14, e0218839. doi:10.1371/journal.pone.0218839. https://pubmed.ncbi.nlm.nih.gov/31596887/
智鼠故事 
